StockData
SLSNNasdaqPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31

SOLESENCE, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.89−0.01 (-0.81%)

Close on Oct 19, 2026

Market cap
$63.06M
P/E (TTM)
–
Dividend yield
–

About Solesence

Perfumes, Cosmetics & Other Toilet Preparations, SIC 2844

Solésence, Inc. develops and manufactures mineral-based skin health, sun care, and cosmetic products, as well as active pharmaceutical ingredients and legacy advanced materials. The company vertically integrates proprietary particle surface treatment and dispersion technologies to produce market-ready, customized white-label, and custom-formulated finished goods, including sunscreens, color cosmetics, and skin care formulations. Additionally, it produces engineered zinc oxide and titanium dioxide ingredients. Solésence serves global prestige beauty and personal care brand partners, alongside corporate customers such as chemical manufacturers.

The company operates development and testing laboratories as well as manufacturing capabilities across two facilities located in the Chicago, Illinois area. It distributes finished consumer products and specialized ingredients to partner brands and customers across domestic and international markets, while maintaining product compliance registrations across several jurisdictions including the United States, Canada, Australia, and Europe. Solésence maintains its principal executive offices in Romeoville, Illinois.

Summary of the business section of Solesence's latest annual report, written by StockData.

Company profile

Company

Legal name
SOLESENCE, INC.
Founded
1989
Headquarters
Romeoville, IL
Address
1319 Marquette Drive 60446
Phone
(630) 771-6078
Employees
115, Dec 31, 2025
Industry
Perfumes, Cosmetics & Other Toilet Preparations
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
RSM US LLP, Milwaukee, Wisconsin

Stock & identifiers

Ticker
SLSN
Exchange
Nasdaq
Shares outstanding
71M, Aug 19, 2026
Public float
$27.25M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
SEC CIK
883107
CUSIP
630079101
ISIN
US6300791018
EIN
36-3687863

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Jess JankowskiPresident, CEO, Director208,450
Laura C. RiffnerChief Financial Officer–
Kevin CuretonChief Operating Officer231,019
R. Janet WhitmoreDirector2,188,607
Laura M. BeresDirector–
Mark E. MillerDirector–

Employees

Headcount reported in annual reports

“December 31, 2025, we had a total of 115 full-time employees, 15 of whom hold advanced degrees.”

Corporate history

Events identified from SEC filings

DateEventDetails
Oct 2, 2026Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 14, 2026Late filingNotification of late filing
Apr 7, 2025ListingRegistration of securities on an exchange (Form 8-A)
Mar 31, 2025Name changeName changed from NANOPHASE TECHNOLOGIES Corp to SOLESENCE, INC.
Aug 16, 2022Late filingNotification of late filing
Mar 29, 2019Late filingNotification of late filing
Nov 15, 2018Late filingNotification of late filing
Feb 1, 2016Name changeName changed from NANOPHASE TECHNOLOGIES CORPORATION to NANOPHASE TECHNOLOGIES Corp
Mar 20, 2012DelistingNotice of delisting from exchange (Form 25)
Mar 7, 2012Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Sep 20, 2011Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jun 1, 2011Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
May 20, 2011Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Dec 23, 2009Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)